Elicora, A. Et Al. 2024. Prognostic significance of T lymphocyte subgroups (CD4 and CD8) in lung cancer patients after neoadjuvant chemotherapy. JOURNAL OF CARDIOTHORACIC SURGERY , no.1 .

Elicora, A., Yaprak Bayrak, B., Vural, Ç., Sezer, H. F., Erkal, S. U., & Metin, E., (2024). Prognostic significance of T lymphocyte subgroups (CD4 and CD8) in lung cancer patients after neoadjuvant chemotherapy. JOURNAL OF CARDIOTHORACIC SURGERY , no.1.

Elicora, AYKUT Et Al. "Prognostic significance of T lymphocyte subgroups (CD4 and CD8) in lung cancer patients after neoadjuvant chemotherapy," JOURNAL OF CARDIOTHORACIC SURGERY , no.1, 2024

Elicora, AYKUT Et Al. "Prognostic significance of T lymphocyte subgroups (CD4 and CD8) in lung cancer patients after neoadjuvant chemotherapy." JOURNAL OF CARDIOTHORACIC SURGERY , no.1, 2024

Elicora, A. Et Al. (2024) . "Prognostic significance of T lymphocyte subgroups (CD4 and CD8) in lung cancer patients after neoadjuvant chemotherapy." JOURNAL OF CARDIOTHORACIC SURGERY , no.1.

@article{article, author={AYKUT ELİÇORA Et Al. }, title={Prognostic significance of T lymphocyte subgroups (CD4 and CD8) in lung cancer patients after neoadjuvant chemotherapy}, journal={JOURNAL OF CARDIOTHORACIC SURGERY}, year=2024}